The COVID-RASi Trial (COVID-19)

Clinical trial NCT04591210 · COMPLETED

Trial details

NCT number: NCT04591210
Sponsor: Ottawa Heart Institute Research Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Cardiovascular Diseases

Start date: 2021-01-27
Primary completion: 2024-12-30
Enrollment: 372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.